Contraindicated. Cobicistat is a CYP3A4 inhibitor; contraindicated with CYP3A4 substrates for which elevated plasma concentrations are associated with major and/or lifetime-threatening occasions.This is more likely to happen from initiation of elranatamab step-up dosing around fourteen times soon after the first treatment method dose And through an